Moreover, we have shown that there was a significant elevation in levels of CD4+CTLA-4+ T cells only in PBMCs of CRC patients with advanced stages, suggesting that there is a relationship between increased levels of CTLA-4+ Tregs and CRC progression [8]. This evidence concerns the gene CD4 and colorectal carcinoma.